Skip to main content
. 2019 Jul 31;188(11):1932–1943. doi: 10.1093/aje/kwz171

Table 4.

Direct and Indirect Effects (Mediated Through Body Mass Index) of Physical Activity on Metabolite Levels in Samples of Participants From the Nurses’ Health Study (1989–1990), Nurses’ Health Study II (1996–1999), and the Health Professionals Follow-up Study (1993–1995)a

Metabolite HMDB ID Effect, β (SE) (×10−3) % of Effect Mediated by BMI
Direct Effect Indirect Effect (Mediated by BMIb) Total Effect
Cholesteryl esters
 C18:2 CE HMDB00610 4.66 (0.79) 0.52 (0.11) 5.18 (0.79) 9.98
 C18:1 CE HMDB00918 3.02 (0.79) 0.48 (0.11) 3.49 (0.79) 13.68
 C16:0 CE HMDB00885 2.84 (0.79) 0.45 (0.10) 3.29 (0.79) 13.57
 C18:3 CE HMDB10370 2.84 (0.81) −0.14 (0.09) 2.70 (0.81) −5.14c
 C22:4 CE HMDB06729 2.69 (1.29) 0.84 (0.16) 3.53 (1.28) 23.89
Phospholipids
 C18:2 LPC HMDB10386 4.46 (0.80) 0.58 (0.12) 5.04 (0.80) 11.44
 C20:5 LPC HMDB10397 3.82 (0.81) 0.39 (0.10) 4.22 (0.81) 9.30
 C18:1 LPC HMDB02815 3.61 (0.80) 0.52 (0.11) 4.13 (0.80) 12.60
 C36:4 PC-A HMDB07983 4.48 (0.81) 0.22 (0.09) 4.70 (0.81) 4.76
 C34:3 PC plasmalogen HMDB11211 3.89 (0.80) 0.48 (0.11) 4.37 (0.80) 11.02
 C36:3 PC plasmalogen HMDB11244 3.36 (0.79) 0.57 (0.11) 3.93 (0.79) 14.54
 C36:2 PC plasmalogen HMDB11243 2.90 (0.78) 0.57 (0.11) 3.47 (0.78) 16.42
 C34:2 PC plasmalogen HMDB11210 2.83 (0.78) 0.57 (0.11) 3.40 (0.78) 16.63
 C36:0 PC HMDB08036 2.91 (0.81) 0.18 (0.09) 3.08 (0.81) 5.68
 C18:2 LPE HMDB11507 2.91 (0.70) 0.22 (0.08) 3.12 (0.70) 6.95
 C18:1 LPE HMDB11506 2.70 (0.71) 0.22 (0.08) 2.92 (0.70) 7.58
 C38:3 PE plasmalogen HMDB11384 2.75 (0.78) 0.51 (0.11) 3.26 (0.78) 15.78
 C40:6 PE HMDB09012 −2.61 (0.78) −0.38 (0.10) −2.99 (0.78) 12.62c
 C38:2 PE HMDB08942 2.41 (0.81) 0.35 (0.10) 2.76 (0.81) 12.76
 C34:0 PI HMDB09805 3.83 (0.81) −0.14 (0.09) 3.68 (0.81) −3.88c
Glycerolipids
 C34:3 DG HMDB07132 −2.59 (0.80) −0.79 (0.13) −3.39 (0.80) 23.36
 C34:2 DG HMDB07103 −2.36 (0.79) −0.84 (0.14) −3.20 (0.80) 26.33
 C32:1 DG HMDB07099 −2.23 (0.79) −0.84 (0.14) −3.07 (0.79) 27.40
 C34:1 DG HMDB07102 −2.16 (0.79) −0.87 (0.14) −3.03 (0.79) 28.71
 C32:0 DG HMDB07098 −2.03 (0.79) −0.84 (0.14) −2.87 (0.79) 29.37
 C50:2 TG HMDB05377 −2.31 (0.78) −0.86 (0.14) −3.17 (0.79) 27.18
 C52:2 TG HMDB05369 −2.19 (0.79) −0.86 (0.14) −3.05 (0.80) 28.15
 C50:3 TG HMDB05433 −2.11 (0.79) −0.81 (0.14) −2.92 (0.80) 27.73
 C50:1 TG HMDB05360 −1.91 (0.78) −0.89 (0.14) −2.79 (0.79) 31.74
Sphingolipids
 C18 carnitine HMDB00848 1.67 (0.57) 0.33 (0.07) 2.00 (0.56) 16.31
Amino acids
 Glycine HMDB00123 1.89 (0.56) 0.71 (0.11) 2.60 (0.57) 27.33
 Citrulline HMDB00904 1.90 (0.55) 0.27 (0.07) 2.16 (0.55) 12.28
 Glutamate HMDB00148 −1.34 (0.56) −0.84 (0.12) −2.19 (0.57) 38.65
 Asparagine HMDB00168 1.43 (0.57) 0.46 (0.09) 1.89 (0.57) 24.25
Others
 1-Methyladenosine HMDB03331 −2.24 (0.56) −0.77 (0.12) −3.02 (0.56) 25.69
 Creatine HMDB00064 −1.60 (0.57) −0.41 (0.08) −2.01 (0.57) 20.31

Abbreviations: BMI, body mass index; CE, cholesteryl ester; DG, diglyceride; HMDB, Human Metabolome Database; ID, identification number; LPC, lysophosphatidylcholines; LPE, lysophosphatidylethanolamine; PC, phosphocholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; SE, standard error; TG, triglyceride.

a Linear regression analysis with adjustment for age (years; continuous), case-control status (case, control), case-control study nested within the 3 cohort studies (16 categories), smoking status (never, past, or current smoker), fasting status at blood collection (yes, no), alcohol intake (g/day; continuous), Alternative Healthy Eating Index score (0–100; continuous), total energy intake (kcal/day; continuous), and intakes of fatty acids (linolenic acid, α-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, oleic acid, stearic acid, and trans- fatty acids).

b BMI is calculated as weight (kg)/height (m)2.

c The mediation effect was not significant.